Citius Oncology Inc.

0.71
0.09 (14.52%)
At close: Mar 24, 2025, 3:58 PM
0.73
2.26%
After-hours: Mar 24, 2025, 05:25 PM EDT

Citius Oncology Income Statement

Year FY24 FY23 FY22 FY21
Revenue n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a
Operating Income -20.57M -12.12M -4.86M n/a
Interest Income n/a n/a n/a n/a
Pretax Income -20.57M -12.12M -4.86M -10.11K
Net Income -21.15M -12.7M -5.43M -10.11K
Selling & General & Admin 15.65M 7.88M 1.43M n/a
Research & Development 4.93M 4.24M 3.43M n/a
Other Expenses n/a n/a n/a n/a
Operating Expenses 20.57M 12.12M 4.86M n/a
Interest Expense n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 20.57M 12.12M 4.86M n/a
Income Tax 576K 576K 576K n/a
Shares Outstanding (Basic) 71.55M 89.48M 90.16M 81.4M
Shares Outstanding (Diluted) 71.55M 89.48M 90.16M 81.4M
EPS (Basic) -0.3 -1.42 -0.6 -0.00
EPS (Diluted) -0.3 -1.42 -0.6 -0.00
EBITDA -20.57M -12.12M -4.86M -10.11K
Depreciation & Amortization n/a n/a n/a n/a